7T MRI Scan for the Early Detection of Melanoma Brain Metastases
NCT04941430 is an interventional trial sponsored by University of Southern California. As of 21 Nov 2026, it was terminated. It studies Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Brain and 2 more conditions. The registry lists an enrollment of 2 participants at 1 site in 1 country. The registry lists a start date of 25 Jun 2021 and a primary completion date of 10 Jan 2025.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04941430 |
| Status | Terminated |
| Study type | Interventional trial |
| Lead sponsor | University of Southern California |
| Enrollment | 2 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma and Pathologic Stage IV Cutaneous Melanoma AJCC v8 |
| Start | 25 Jun 2021 |
| Primary completion | 10 Jan 2025 |
| Study completion | 10 Jan 2025 |
| Last update posted | 12 Aug 2025 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Lindsay Hwang
University of Southern California
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usc / Norris Comprehensive Cancer Center
Los Angeles
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04941430
Each answer restates registry values shown on this page.
What is NCT04941430?
NCT04941430 is an interventional trial sponsored by University of Southern California. It studies Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Brain and 2 more conditions.
Who leads NCT04941430?
The registry names Lindsay Hwang (principal investigator, University of Southern California) as the overall official.
Where does NCT04941430 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT04941430 end?
The registry lists a primary completion date of 10 Jan 2025 and a study completion date of 10 Jan 2025. The sponsor last updated the record on 12 Aug 2025.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.